ENTITY

Immunogen Inc (IMGN US)

12
Analysis
Health CareUnited States
ImmunoGen, Inc. develops targeted anticancer therapeutics using its Targeted Antibody Payload (TAP) technology together with its expertise in monoclonal antibodies and tumor biology. A TAP compound uses a tumor-targeting monoclonal antibody to deliver one of ImmunoGen's purpose-developed cancer-killing agents specifically to tumor cells.
more
Refresh
Company Event30 Nov 2023 22:00 • Upcoming
Add To Calendar
Company Event02 Nov 2023 20:00 • Latest
Company Event02 Nov 2023 05:00 • Upcoming
Add To Calendar
Company Event31 Jul 2023 20:00
Company Event03 May 2023 20:00
x